Published in Biomed Res Int on July 29, 2013
Novel chitosan/diclofenac coatings on medical grade stainless steel for hip replacement applications. Sci Rep (2016) 0.75
Structural-Geometric Functionalization of the Additively Manufactured Prototype of Biomimetic Multispiked Connecting Ti-Alloy Scaffold for Entirely Noncemented Resurfacing Arthroplasty Endoprostheses. Appl Bionics Biomech (2017) 0.75
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum (2000) 11.84
Femoral neck fractures following Birmingham hip resurfacing: a national review of 50 cases. J Bone Joint Surg Br (2005) 3.56
Femoral neck fractures after metal-on-metal total hip resurfacing: a prospective cohort study. J Arthroplasty (2007) 1.75
Complications associated with hip resurfacing arthroplasty. Orthop Clin North Am (2005) 1.59
Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop Relat Res (1992) 1.58
Eleven years of experience with metal-on-metal hybrid hip resurfacing: a review of 1000 conserve plus. J Arthroplasty (2008) 1.53
Fracture of the neck of the femur after surface arthroplasty of the hip. J Bone Joint Surg Am (2004) 1.53
High complication rate after revision of large-head metal-on-metal total hip arthroplasty. Clin Orthop Relat Res (2014) 1.38
Poor outcome of revised resurfacing hip arthroplasty. Acta Orthop (2010) 1.34
Causes of early failure in a multicenter clinical trial of hip resurfacing. J Arthroplasty (2008) 1.27
Quantitative morphology of the subchondral plate of the tibial plateau. J Anat (1994) 1.23
Resurfacing arthroplasty of the hip for avascular necrosis of the femoral head: a minimum follow-up of four years. J Bone Joint Surg Br (2010) 1.02
Osteonecrosis following resurfacing arthroplasty. Acta Orthop (2009) 0.99
What's new in hip arthroplasty. J Bone Joint Surg Am (2006) 0.97
Hip resurfacing: why does it fail? Early results and critical analysis of our first 60 cases. Int Orthop (2007) 0.94
Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res (2000) 0.91
Femoral neck narrowing after metal-on-metal hip resurfacing. J Arthroplasty (2008) 0.89
Hip resurfacing and osteonecrosis: results from an independent hip resurfacing register. Arch Orthop Trauma Surg (2010) 0.85
Influence of cell isolation, cell culture density, and cell nutrition on differentiation of rat calvarial osteoblast-like cells in vitro. Eur Cell Mater (2001) 0.85
Prototype of minimally invasive hip resurfacing endoprosthesis - bioengineering design and manufacturing. Acta Bioeng Biomech (2009) 0.84
Hip resurfacing: a systematic review of literature. Int Orthop (2012) 0.83
[Blood flow to the femoral head and hip resurfacing arthroplasty]. Orthopade (2008) 0.80
Factors affecting the cement penetration of a hip resurfacing implant: an in vitro study. Hip Int (2006) 0.79
Clinical and radiographic findings in multiple epiphyseal dysplasia caused by MATN3 mutations: description of 12 patients. Am J Med Genet A (2004) 0.98
Prototype of minimally invasive hip resurfacing endoprosthesis - bioengineering design and manufacturing. Acta Bioeng Biomech (2009) 0.84
Anticancer effect of A-ring or/and C-ring modified oleanolic acid derivatives on KB, MCF-7 and HeLa cell lines. Org Biomol Chem (2012) 0.79
New intermediate phenotype between MED and DD caused by compound heterozygous mutations in the DTDST gene. Am J Med Genet A (2010) 0.76
Oleanolic Acid A-lactams Inhibit the Growth of HeLa, KB, MCF-7 and Hep-G2 Cancer Cell Lines at Micromolar Concentrations. Anticancer Agents Med Chem (2016) 0.76
A two year observation of the process of applying recombinant IGF-1 to treat short stature in children with primary IGF-1 deficiency -- case reports of 3 patients. Pediatr Endocrinol Diabetes Metab (2011) 0.76
Methanol poisoning--case report. Przegl Lek (2005) 0.75
In vitro cytostatic activity of 8-substituted and tricyclic analogues of acyclovir. Pol J Pharmacol (2002) 0.75
[The influence of patient age and duration time of symptoms on the long-term outcome of surgical treatment]. Chir Narzadow Ruchu Ortop Pol (2002) 0.75
Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry. Kardiol Pol (2015) 0.75
[Minimally invasive technique in surgical treatment of carpal tunnel syndrome and cubital tunnel syndrome]. Chir Narzadow Ruchu Ortop Pol (2007) 0.75
Synthesis of 3'-azido-2',3'-dideoxy-5-fluorouridine phosphoramidates and evaluation of their anticancer activity. Eur J Med Chem (2013) 0.75
Algorithm of physical therapy exercises following total hip arthroplasty. Pol Orthop Traumatol (2013) 0.75
Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT). Bioorg Med Chem (2011) 0.75
Expression of neuroendocrine markers in endometrial carcinomas - an immunohistochemical analysis. Folia Histochem Cytobiol (2012) 0.75
Synthesis of novel 2',3'-didehydro-2',3'-dideoxyinosine phosphoramidate prodrugs and evaluation of their anticancer activity. Nucleosides Nucleotides Nucleic Acids (2014) 0.75